trial

Home-based Transcranial Direct Current Stimulation (tDCS) for Behavioral Symptoms in Alzheimer's Disease and Related Dementias (ADRD)

NCTId NCT05478681
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 3 (actual)
Sponsored by The University of Texas Health Science Center, Houston
Primary completion 2024-02-26
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
3 (actual)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2023-04-17
Primary completion
2024-02-26
Eligibility
ALL · 60 Years

Interventions & indications

Drugs
Active TDCS

Sponsors

The University of Texas Health Science Center, HoustonLead Sponsor
Texas Alzheimer's Research and Care ConsortiumCollaborator

Investigators

2
Kendra M Anderson, PhDPrincipal Investigator
Antonio L Teixeira, MDPrincipal Investigator

Sites

2 total
Houston, United StatesSan Antonio, United States

Facts & assertions

4 sourced
Enrollment
3
Phase
NA
Primary Completion Date
2024-02-26
Status
COMPLETED
relationships
The graph out of here
drug
Active TDCS
drug
lead_sponsor
The University of Texas Health Science Center, Houston
company
collaborator
Texas Alzheimer's Research and Care Consortium
company
indication
Alzheimer Disease
indication
Psychotic Disorders
indication
Lethargy
indication
investigator
Kendra M Anderson, PhD
person
Antonio L Teixeira, MD
person